François Y, Grandclément E, Sayag-Beaujard A C, Glehen O, Sadeghi-Looyeh B, Bienvenu J, Peyrat P P, Garbit F, Vignal J, Gilly F N
Service de Chirurgie, Centre Hospitalo-Universitaire Lyon-Sud, Pierre-Bénite.
J Chir (Paris). 1997 Nov;134(5-6):237-42.
We report 42 cases of gastric cancer with peritoneal carcinosis treated with intraperitoneal chemohyperthermia. Intraperitoneal chemohyperthermia was achieved with a closed sterile circuit containing mitomycin C, 10 mg/l producing an input temperature varying from 46 to 49 degrees C for 90 minutes. There were three postoperative deaths: one pulmonary embolism at day 4, one multiple organ failure et day 4, and one septic shock at day 25 due to a colonic fistula. Two patients suffered complications: one opening of the duodenal stump requiring reoperation on day 5, and one prolonged postoperative ileus lasting to day 10. Of the 12 patients with ascites, resorption was achieved in 8. In patients with early-stage peritoneal carcinosis (granulations less than 5 mm) survival at 1, 2 and 3 years was 90%, 61% and 41% respectively. For those with more extensive carcinosis, survival at 1 year was 10%. Five patients survived more than 30 months, three have survived to 34, 43 and 73 months. Intraperitoneal chemohyperthermia is a new treatment for carcinosis of gastric origin. These early results must be assessed further with larger controlled.
我们报告了42例接受腹腔内热化疗的胃癌伴腹膜转移患者。腹腔内热化疗通过一个封闭的无菌回路实现,回路中含有丝裂霉素C,浓度为10 mg/l,输入温度在46至49摄氏度之间,持续90分钟。术后有3例死亡:1例在术后第4天发生肺栓塞,1例在术后第4天发生多器官功能衰竭,1例在术后第25天因结肠瘘发生感染性休克。2例患者出现并发症:1例十二指肠残端裂开,在术后第5天需要再次手术;1例术后肠梗阻持续至第10天。12例腹水患者中,8例腹水吸收。早期腹膜转移(肉芽小于5 mm)患者1年、2年和3年生存率分别为90%、61%和41%。对于腹膜转移更广泛的患者,1年生存率为10%。5例患者存活超过30个月,3例分别存活至34、43和73个月。腹腔内热化疗是胃癌源性腹膜转移的一种新治疗方法。这些早期结果必须通过更大规模的对照研究进一步评估。